Sohrab Arora
Urology · Fort Worth, TXNPI 1033654769
Payments from drug & device makers
Across 50 payments — averaging $472.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Trinity Urology Solutions, LLC$21K
- Procept Biorobotics Corporation$1K
- EDAP Technomed Inc$384
- Boston Scientific$326
- Calyxo, Inc.$218
- Cook Medical LLC$167
- plus $847 from 16 others
What the payments were for
- Travel & lodging$82527%
- Food & beverage$2,18573%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Trinity Urology Solutions, LLC | 1 | $20,618 |
| Procept Biorobotics Corporation | 9 | $1,068 |
| EDAP Technomed Inc | 4 | $384 |
| Boston Scientific | 11 | $326 |
| Calyxo, Inc. | 2 | $218 |
| Cook Medical LLC | 4 | $167 |
| Palette Life Sciences, Inc. | 1 | $151 |
| Ferring Pharmaceuticals Inc. | 3 | $130 |
| Laborie Medical Technologies Corp. | 1 | $112 |
| Ambu Inc. | 1 | $93 |
| Agiliti Surgical, Inc. | 1 | $57 |
| Bluewind Medical | 1 | $46 |
| Conmed Corporation | 1 | $45 |
| Avation Medical, Inc. | 2 | $44 |
| Novartis | 1 | $34 |
| Telix Pharmaceuticals | 1 | $24 |
| Myovant Sciences Inc. | 1 | $21 |
| Coloplast | 1 | $20 |
| Urogen Pharma, Inc. | 1 | $20 |
| 180 Medical, Inc. | 1 | $20 |
| Teleflex LLC | 1 | $16 |
| AbbVie | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$23,628 in reported general payments places this provider in the 80th percentile of 878 urology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 27 | $146 |
| Methocarbamol | 18 | $67 |
| Oxybutynin Chloride | 13 | $52 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 34 | $43 |
Paid to pharmacies, not to this prescriber.
Other urology in Fort Worth
- Michael ColliniFort Worth$183K
- Zvi SchiffmanHouston$17.8M
- Jose de la CerdaSan Antonio$9M
- Daniel SaltzsteinSan Antonio$5.8M
- Jose KaramHouston$5.7M
- Daniel ZainfeldSan Antonio$4.7M
- Brian MazzarellaLakeway$4.5M
- Andrew von EschenbachMontgomery$3.2M
- Raj SatkunasivamHouston$2.6M
- Alan SkolnickHouston$2.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.